## **Trustees’ Annual Report for the period** **From 16.06.2022 Period start date To 31.12.2022** ## **Period end date** **Charity name: UK Acute Oncology Society** **Charity registration number: 1199351** ## **Objectives and Activities** **----- Start of picture text -----**
SORP reference
Summary of the purposes of Para 1.17  For the public benefit, to advance the
the charity as set out in its education of all healthcare professionals
governing document involved in treating or supporting patients
in the field of acute oncology.
 In furtherance of the object above, to
promote research for the public benefit in
all aspects of that subject and to publish
the useful results.
 The relief of sickness and preservation of
health, from cancer, among people
residing permanently or temporarily in the
UK.
 To assist in the treatment and care of
persons suffering from cancer, or in need
of rehabilitation, by the provision of
education for healthcare professionals.
 To promote the wellbeing of people
suffering from acute effects of cancer
and/or anti-cancer treatment and support
the development of acute oncology
services in the UK through assisting in
the provision of education.
Summary of the main Para 1.17 and 1. Provision of forum for Health Care
1.19
activities in relation to those professionals supporting emergency
purposes for the public cancer care.
benefit, in particular, the 2. Annual educational programme.
activities, projects or 3. Website and educational resources.
services identified in the 4. Supporting service innovation, shared
accounts. learning and research promotion.
Statement confirming Para 1.18 The UKAOS trustees have had regard to the
whether the trustees have guidance issued by the Charity Commission
had regard to the guidance on public benefit.
issued by the Charity
Commission on public
benefit
**----- End of picture text -----**
**Additional information (optional)** You may choose to include further statements where relevant about: SORP reference Para 1.38 Policy on grant making Para 1.38 Policy on social investment including program related investment Para 1.38 Contribution made by volunteers Other ## **Achievements and Performance** **----- Start of picture text -----**
SORP reference
**----- End of picture text -----**
|**Achievements and Performance**|**Achievements and Performance**|**Achievements and Performance**| |---|---|---| |SORP reference||| |Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.|Para 1.20|Acute Oncology and New Models of Same
Day Emergency Care (SDEC): A one-day
MDT Conference, held at Hilton Leeds City
Centre, Neville Street, Leeds LS1 4BX, on
27 April 2022, attended by over 80
delegates.
Society representation at – UK Oncology
Forum, June 2022; National Oncology
SDEC Forum, August 2022; The Society for
Acute Medicine Conference, September
2022.
UKAOS website:
www.ukacuteoncology.co.uk
with educational resources.
Production and distribution of quarterly
members’Newsletters.| ## **Additional information (optional)** You may choose to include further statements where relevant about: |**Additional information (optional)**
You may choose to include further statements where relevant about:|**Additional information (optional)**
You may choose to include further statements where relevant about:|**Additional information (optional)**
You may choose to include further statements where relevant about:| |---|---|---| |||| |Achievements against
objectives set|Para 1.41|| |Performance of fundraising
activities against objectives
set|Para 1.41|| |||| |---|---|---| |Investment performance
against objectives|Para 1.41|| |Other||| ## **Financial Review** **----- Start of picture text -----**
Review of the charity’s Para 1.21 Details of receipts and payments are given
financial position at the end in the Receipts and Payments Account
of the period within the financial statements. The total
unrestricted funds as at 31 December 2022
amounted to £4,494.
Statement explaining the Para 1.22 To fund future projects.
policy for holding reserves
stating why they are held
Amount of reserves held Para 1.22 The free reserves at 31 December 2022 are
£4,494 and the trustees are satisfied that
this level of reserves is sufficient to meet the
needs of the charity in its early stages of
development.
Reasons for holding zero Para 1.22 Not applicable.
reserves
Details of fund materially in Para 1.24 None.
deficit
Explanation of any Para 1.23 There are no uncertainties about the charity
uncertainties about the continuing as a going concern.
charity continuing as a going
concern
**----- End of picture text -----**
## **Additional information (optional)** You may choose to include further statements where relevant about: |**Additional information (optional)**
You may choose to include further statements where relevant about:|**Additional information (optional)**
You may choose to include further statements where relevant about:|**Additional information (optional)**
You may choose to include further statements where relevant about:| |---|---|---| |||| |The charity’s principal
sources of funds (including
any fundraising)|Para 1.47|| |Investment policy and
objectives including any
social investment policy
adopted|Para 1.46|| |A description of the principal
risks facing the charity|Para 1.46|| |Other||| ## **Structure, Governance and Management** |Description of charity’s
trusts:||| |---|---|---| |Type of governing document
(trust deed, royal charter)|Para 1.25|Constitution.| |How is the charity
constituted?
(e.g unincorporated
association, CIO)|Para 1.25|Charitable Incorporated Organisation (CIO)| |Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees|Para 1.25|Election by UKAOS members at Annual
General Meeting.| **Additional information (optional)** You may choose to include further statements where relevant about: |**Additional information (optional)**
You may choose to include further statements where relevant about:|**Additional information (optional)**
You may choose to include further statements where relevant about:|**Additional information (optional)**
You may choose to include further statements where relevant about:| |---|---|---| |||| |Policies and procedures
adopted for the induction
and training of trustees|Para 1.51|| |The charity’s organisational
structure and any wider
network with which the
charity works|Para 1.51|| |Relationship with any related
parties|Para 1.51|| |Other||| ## **Reference and Administrative details** **----- Start of picture text -----**
Charity name UK Acute Oncology Society
Other name the charity uses UKAOS
Registered charity number 1199351
Charity’s principal address Right Angle Communications Ltd
Parkshot House
5 Kew Road
Richmond
TW9 2PR
**----- End of picture text -----**
## **Names of the charity trustees who manage the charity** **----- Start of picture text -----**
Dates acted if not for whole Name of person (or body) entitled
Trustee name Office (if any)
year to appoint trustee (if any)
Dr E Marshall Chair 16.06.2022 to
1
31.12.2022
Dr C Mitchell 16.06.2022 to
2
31.12.2022
Dr H J Williams Treasurer 16.06.2022 to
3
31.12.2022
P J Jones 16.06.2022 to
4
31.12.2022
N R Clatworthy 16.06.2022 to
5
31.12.2022
Dr C Wilson 16.06.2022 to
6
31.12.2022
7
8
9
10
11
12
13
14
15
16
17
18
19
20
**----- End of picture text -----**
## – Corporate trustees names of the directors at the date the report was approved ## **Director name** Name of trustees holding title to property belonging to the charity **Trustee name Dates acted if not for whole year** ## **Funds held as custodian trustees on behalf of others** Description of the assets None. held in this capacity Name and objects of the Not applicable. charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for Not applicable. safe custody and segregation of such assets from the charity’s own assets ## **Additional information (optional)** ## **Names and addresses of advisers (Optional information)** |**Type of**|**Name**|**Address**| |---|---|---| |**adviser**||| ## **Name of chief executive or names of senior staff members (Optional information)** ## **Exemptions from disclosure** Reason for non-disclosure of key personnel details Not applicable. ## **Other optional information** ## **Declarations** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s) Full name(s)** Dr Hilary Williams **Position (eg Secretary,** Treasurer **Chair, etc) Date** 19/10/2023 ||**UK Acute Oncology Society (UKAOS)**
**Charity Name**|**UK Acute Oncology Society (UKAOS)**
**Charity Name**|**UK Acute Oncology Society (UKAOS)**
**Charity Name**|**1199351**
**No (if any)**|**1199351**
**No (if any)**|**1199351**
**No (if any)**|**CC16a**| |---|---|---|---|---|---|---|---| ||**For the period**
**from**|16-Jun-22
Period start date|**To**||31-Dec-22
Period end date||| ||||||||| |**Section A Receipts and payments**|||||||| |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest**
**£**
**3,300**
**1,194 **
**-**
**-**
**-**
**-**
**-**
**-**
**4,494**
**-**
**-**
**-**
**4,494**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**4,494**
**-**
**-**
**4,494**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**Total funds**
**to the nearest £**
**3,300**
**1,194 **
**-**
**-**
**-**
**-**
**-**
**-**
**4,494**
**-**
**-**
**-**
**4,494**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**4,494**||**Last year**
**to the nearest £**| |Donations|**3,300**||||||**-**| |SDECmeeting surplus|**1,194 **||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| |**_Sub total_**_(Gross income for_
_AR)_|**4,494**||||||**-**| ||||||||| |**A2 Asset and investment sales,**
**(see table).**|||||||| ||**-**||||||| ||**-**||||||**-**| |**_Sub total_**|**-**||||||**-**| |**_Total receipts_ **
**A3 Payments**|||||||| ||||||||**-**| ||||||||| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| |**_Sub total_ **|**-**||||||**-**| ||||||||| |**A4 Asset and investment**
**purchases, (see table)**|||||||| ||**-**||||||| ||**-**||||||| |**_Sub total_ **|**-**||||||**-**| |**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||||| ||||||||**-**| ||||||||| ||**4,494**|**-**|**-**||**4,494**||**-**| ||**-**|**-**|**-**||**-**||**-**| ||**-**|**-**|**-**||**-**||**-**| ||**4,494**|**-**|**-**||**4,494**||**-**| CCXX R1 accounts (SS) 04/10/2023 1 ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|**Details**
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
Bank
**Details**
Signature|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**4,494**
**-**
**-**
**-**
**-**
**-**
**4,494**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
Dr HilaryWilliams|**Endowment**
**funds**
**to nearest £**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| |||Dr HilaryWilliams|19/10/2023| ||||| CCXX R2 accounts (SS) 04/10/2023 2